Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;16(Suppl 1):17S–27S. doi: 10.1111/j.1365-2125.1983.tb02267.x

Preclinical pharmacology of midazolam

L Pieri
PMCID: PMC1428106  PMID: 6138073

Abstract

1 Midazolam, a new imidazobenzodiazepine, forms salts that are stable in water solution, and has an overall pharmacological potency similar to that of diazepam but a much shorter duration of action. It produces all the characteristic effects of the benzodiazepine class.

2 Its metabolites account for only a negligible part, if any, of its pharmacological effects observed in the mouse.

3 The time course of its anticonvulsant activity, studied with different experimental protocols and by different routes of administration, revealed an almost immediate onset of action.

4 Midazolam was lightly more potent, and its duration of action was shorter than diazepam, in enhancing presynaptic inhibition in the spinal cord of cats and in depressing spontaneous activity of cerebellar Purkinje cells in the rat.

5 Midazolam decreased spontaneous multiunit activity (MUA) in different nuclei of the brain in `encéphale isolé' rats. This depression was reversed by Ro 15-1788, a recently discovered selective benzodiazepine antagonist.

6 Midazolam and diazepam decreased the cyclic GMP level in the cerebellum of rats with about the same potency; the effect of midazolam was of much shorter duration than that of diazepam.

7 Midazolam had one-third the potency of diazepam in displacing 3H-flunitrazepam in mouse brain in vivo, and also in this case the effect of midazolam was of brief duration, as compared with diazepam.

8 Midazolam in therapeutic doses was virtually ineffective in the cardiovascular system of conscious dogs after p.o. or i.v. administration. No direct effects of the drug on autonomic functions were found.

9 The animal data suggest the usefulness of midazolam as an oral sleep-inducer, as an agent for i.v. induction of anaesthesia and as an i.v. or i.m. anticonvulsant in status epilepticus or tetanus, because of its rapid onset of action and its excellent local tolerance as water-soluble injection form.

Full text

PDF
17S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biggio G., Brodie B. B., Costa E., Guidotti A. Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex. Proc Natl Acad Sci U S A. 1977 Aug;74(8):3592–3596. doi: 10.1073/pnas.74.8.3592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DUNHAM N. W., MIYA T. S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Am Pharm Assoc. 1957 Mar;46(3):208–209. doi: 10.1002/jps.3030460322. [DOI] [PubMed] [Google Scholar]
  3. Da Prada M., Zürcher Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci. 1976 Oct 15;19(8):1161–1174. doi: 10.1016/0024-3205(76)90251-4. [DOI] [PubMed] [Google Scholar]
  4. Davidson A. B., Cook L. Effects of combined treatment with trifluoperazine-HCl and amobarbital on punished behavior in rats. Psychopharmacologia. 1969;15(3):159–168. doi: 10.1007/BF00411166. [DOI] [PubMed] [Google Scholar]
  5. Gerecke M. Chemical structure and properties of midazolam compared with other benzodiazepines. Br J Clin Pharmacol. 1983;16 (Suppl 1):11S–16S. doi: 10.1111/j.1365-2125.1983.tb02266.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Glusman M. The hypothalamic "savage" syndrome. Res Publ Assoc Res Nerv Ment Dis. 1974;52:52–92. [PubMed] [Google Scholar]
  7. Haefely W., Kulcsár A., Möhler H., Pieri L., Polc P., Schaffner R. Possible involvement of GABA in the central actions of benzodiazepines. Adv Biochem Psychopharmacol. 1975;(14):131–151. [PubMed] [Google Scholar]
  8. Heizmann P., Eckert M., Ziegler W. H. Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol. 1983;16 (Suppl 1):43S–49S. doi: 10.1111/j.1365-2125.1983.tb02270.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hunkeler W., Möhler H., Pieri L., Polc P., Bonetti E. P., Cumin R., Schaffner R., Haefely W. Selective antagonists of benzodiazepines. Nature. 1981 Apr 9;290(5806):514–516. doi: 10.1038/290514a0. [DOI] [PubMed] [Google Scholar]
  10. Malick J. B. Effects of selected drugs on stimulus-bound emotional behavior elicited by hypothalamic stimulation in the cat. Arch Int Pharmacodyn Ther. 1970 Jul;186(1):137–141. [PubMed] [Google Scholar]
  11. Murasaki M., Hara T., Oguchi T., Inami M., Ikeda Y. Action of enpiprazole on emotional behavior induced by hypothalamic stimulation in rats and cats. Psychopharmacology (Berl) 1976 Sep 29;49(3):271–274. doi: 10.1007/BF00426829. [DOI] [PubMed] [Google Scholar]
  12. Pieri L., Haefely W. The effect of diphenylhydantoin, diazepam and clonazepam on the activity of Purkinje cells in the rat cerebellum. Naunyn Schmiedebergs Arch Pharmacol. 1976 Dec;296(1):1–4. doi: 10.1007/BF00498833. [DOI] [PubMed] [Google Scholar]
  13. Pieri L., Schaffner R., Scherschlicht R., Polc P., Sepinwall J., Davidson A., Möhler H., Cumin R., Da Prada M., Burkard W. P. Pharmacology of midazolam. Arzneimittelforschung. 1981;31(12A):2180–2201. [PubMed] [Google Scholar]
  14. Polc P., Laurent J. P., Scherschlicht R., Haefely W. Electrophysiological studies on the specific benzodiazepine antagonist Ro 15-1788. Naunyn Schmiedebergs Arch Pharmacol. 1981 Jul;316(4):317–325. doi: 10.1007/BF00501364. [DOI] [PubMed] [Google Scholar]
  15. Polc P., Möhler H., Haefely W. The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(4):319–337. doi: 10.1007/BF00504702. [DOI] [PubMed] [Google Scholar]
  16. SWINYARD E. A., BROWN W. C., GOODMAN L. S. Comparative assays of antiepileptic drugs in mice and rats. J Pharmacol Exp Ther. 1952 Nov;106(3):319–330. [PubMed] [Google Scholar]
  17. Scherschlicht R., Marias J. Effects of oral and intravenous midazolam, triazolam and flunitrazepam on the sleep-wakefulness cycle of rabbits. Br J Clin Pharmacol. 1983;16 (Suppl 1):29S–35S. doi: 10.1111/j.1365-2125.1983.tb02268.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sepinwall J., Grodsky F. S., Cook L. Conflict behavior in the squirrel monkey: effects of chlordiazepoxide, diazepam and N-desmethyldiazepam. J Pharmacol Exp Ther. 1978 Jan;204(1):88–102. [PubMed] [Google Scholar]
  19. Williamson M. J., Paul S. M., Skolnick P. Labelling of benzodiazepine receptors in vivo. Nature. 1978 Oct 12;275(5680):551–553. doi: 10.1038/275551a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES